ADIL
NASDAQ · Pharmaceuticals
Adial Pharmaceuticals Inc
$4.63
-0.17 (-3.54%)
Open$4.81
Previous Close$4.80
Day High$4.88
Day Low$4.56
52W High$280.62
52W Low—
Volume—
Avg Volume90.3K
Market Cap9.10M
P/E Ratio—
EPS$-9.93
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+279.5% upside
Current
$4.63
$4.63
Target
$17.57
$17.57
$13.09
$17.57 avg
$22.70
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 13.49M | 12.56M | 11.54M |
| Net Income | 2.10M | 2.52M | 1.69M |
| Profit Margin | 15.6% | 20.1% | 14.6% |
| EBITDA | 3.80M | 3.63M | 3.04M |
| Free Cash Flow | 1.15M | 1.06M | 1.39M |
| Rev Growth | +2.7% | +18.2% | +12.4% |
| Debt/Equity | 0.15 | 0.14 | 0.18 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |